Little is known on IGF1-mediated activation of mTORC2 signaling in AML60, but we show that IGF1R expression is diminished on MLL-AF9+ AML cells, suggesting that AML cells may be less sensitive to variation in IGF1 levels and mTORC2 signaling. The gene discussed is IGF1R; the disease is acute myeloid leukemia.